Gupta Shalabh K. 4
4 · Unicycive Therapeutics, Inc. · Filed Jul 26, 2021
Insider Transaction Report
Form 4
Gupta Shalabh K.
DirectorCEO
Transactions
- Award
Stock Options
2021-07-15+116,279→ 218,023 totalExercise: $5.00Exp: 2031-07-15→ Common Stock (116,279 underlying)
Footnotes (1)
- [F1]The stock options vest equally over a period of three years from the date of grant.